New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress
about
The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosisSulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician's Expectation Be Matched by the Reality?Mechanistic Perspectives of Maslinic Acid in Targeting InflammationEffect of redox modulating NRF2 activators on chronic kidney diseaseOxidative stress and nucleic acid oxidation in patients with chronic kidney diseaseChanges in Renal Function and Oxidative Status Associated with the Hypotensive Effects of Oleanolic Acid and Related Synthetic Derivatives in Experimental AnimalsTopical application of the synthetic triterpenoid RTA 408 activates Nrf2 and induces cytoprotective genes in rat skinA generalizable platform for interrogating target- and signal-specific consequences of electrophilic modifications in redox-dependent cell signalingSmall molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agentsCitral alleviates an accelerated and severe lupus nephritis model by inhibiting the activation signal of NLRP3 inflammasome and enhancing Nrf2 activationCitral is renoprotective for focal segmental glomerulosclerosis by inhibiting oxidative stress and apoptosis and activating Nrf2 pathway in miceAntileishmanial activity of semisynthetic lupane triterpenoids betulin and betulinic acid derivatives: synergistic effects with miltefosineA synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancerCombinatorial biosynthesis of sapogenins and saponins in Saccharomyces cerevisiae using a C-16α hydroxylase from Bupleurum falcatum.A synthetic chalcone as a potent inducer of glutathione biosynthesisThe synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease.Inhibition of transglutaminase 2, a novel target for pulmonary fibrosis, by two small electrophilic molecules.Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis.Proteomic analysis shows synthetic oleanane triterpenoid binds to mTORA novel synthetic oleanane triterpenoid suppresses adhesion, migration, and invasion of highly metastatic melanoma cells by modulating gelatinase signaling axis.Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.Emerging drugs for chronic kidney disease.Oleanane triterpenoids in the prevention and therapy of breast cancer: current evidence and future perspectives.Novel Nrf2 activators from microbial transformation products inhibit blood-retinal barrier permeability in rabbits.A library of 1,2,3-triazole-substituted oleanolic acid derivatives as anticancer agents: design, synthesis, and biological evaluation.CDDO-methyl ester delays breast cancer development in BRCA1-mutated mice.Topical application of RTA 408 lotion activates Nrf2 in human skin and is well-tolerated by healthy human volunteersCancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.Bardoxolone Methyl Prevents Fat Deposition and Inflammation in Brown Adipose Tissue and Enhances Sympathetic Activity in Mice Fed a High-Fat DietPharmacological induction of heme oxygenase-1 by a triterpenoid protects neurons against ischemic injury.Bioactive diterpenoid containing a reversible "spring-loaded" (E,Z)-dieneone Michael acceptorRutin, a Flavonoid That Is a Main Component of Saussurea involucrata, Attenuates the Senescence Effect in D-Galactose Aging Mouse Model.Synthetic Triterpenoid Inhibition of Human Ghrelin O-Acyltransferase: The Involvement of a Functionally Required Cysteine Provides Mechanistic Insight into Ghrelin Acylation.Bardoxolone methyl decreases megalin and activates nrf2 in the kidney.Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease.Antihyperglycemic and hypolipidemic effects of α, β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice.Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunitiesChemical and biological mechanisms of phytochemical activation of Nrf2 and importance in disease preventionTriterpenoids and flavonoids from Cecropia schreberiana Miq. (Urticaceae)The synthetic triterpenoid, RTA 405, increases the glomerular filtration rate and reduces angiotensin II-induced contraction of glomerular mesangial cells
P2860
Q21559629-4ECF1110-8FC2-488D-984D-DC59BC89478CQ26765790-C2EAF909-0E0E-4916-8D9C-79609E10D1FAQ26780534-0E9A7BA1-878C-42A9-9AF6-DE141F1F7F70Q26827726-FAB02EF7-1A5D-448D-93F4-59616E2A2EB5Q27006908-38792DD1-1F4C-48E3-9AFE-804D58F03A39Q27305609-546D63EE-0A55-4BDF-8D5D-058B7200C04DQ28304535-B8B0248A-3D80-4ED7-9E46-388110E300ADQ28385286-0B0FE268-E9AC-464C-98D9-4B6A877C9FA9Q28386244-CCC9F127-3172-4594-B73E-D742966EB4A6Q28394337-C061093C-2394-4A6A-AD8A-2622451498EBQ28533529-BEB6EB25-AE19-46E6-B9F1-B08FC2AE4196Q28541041-260982C1-F17E-409D-8A82-FCFA4422FEECQ28543036-C0AE771F-4E3D-41A0-9EAF-71ECF9AE7490Q30570482-59110E21-BEFE-4251-BCA5-708BC130722AQ33631139-6B685A87-1B17-4CC7-8828-A332C2E9A86CQ33716356-821B5416-C1D9-4ACD-904C-A83E3352DE3EQ33799573-56EF5672-70E4-4184-9D46-2EC5DFB9788CQ33872540-0B2A2F22-10D8-4F0A-B65F-983171517859Q33983503-EFF179E0-3F56-43D3-A1AF-310932246A4CQ34022900-D3A98455-B501-4135-8BEF-099FC0AE72E7Q34415403-CF91723F-45E4-4F9D-89DE-517EB9F7CC15Q34420383-D3B9232D-A352-4042-8425-14FC4EDFC166Q34479307-D1D222C5-484B-4FCA-8A75-2C3A27F65CECQ35111445-97374F26-989A-4887-AEB1-710AF9DDC676Q35491894-46095540-3AD3-49DF-931A-FA14EA23B2A9Q35656210-ED76C5BA-7196-47A4-A47E-3D02296C78D9Q35690117-AEB6AFE9-E0A9-46C1-9542-466AFF5585DFQ35753567-48AF4389-C692-4F2C-8E11-8CF6574CB211Q35808984-C86079B2-4211-4745-9CA2-1B86C79876C8Q35911185-42C65174-5283-4343-B68C-42CCBCE63A17Q36135341-1E613059-04D9-4E9B-8158-85DB26E1E39EQ36200083-AC7D9421-40DF-4C69-84D2-192D95111253Q36263619-4DFAAF90-088E-4453-B7B2-72D6ECF696C9Q36280389-90928D5F-4027-408E-91C1-EF3D36244BE5Q36293645-1B64069F-8DD5-4999-8B5A-53151AF71AA9Q36356565-C8634704-827E-4CA3-B83C-3C906C5A14F1Q36444085-0349F0A2-1801-4381-B22D-0E0D5FA5C493Q36539849-283CA880-0D1D-4251-88D7-03D685F44C57Q36634378-EDBE13B0-5BCF-499C-9D38-704A2A8586DFQ36692616-AC00ED3A-26F9-4D72-98EF-FF491205FE6F
P2860
New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
New synthetic triterpenoids: p ...... lammatory and oxidative stress
@ast
New synthetic triterpenoids: p ...... lammatory and oxidative stress
@en
New synthetic triterpenoids: p ...... lammatory and oxidative stress
@nl
type
label
New synthetic triterpenoids: p ...... lammatory and oxidative stress
@ast
New synthetic triterpenoids: p ...... lammatory and oxidative stress
@en
New synthetic triterpenoids: p ...... lammatory and oxidative stress
@nl
prefLabel
New synthetic triterpenoids: p ...... lammatory and oxidative stress
@ast
New synthetic triterpenoids: p ...... lammatory and oxidative stress
@en
New synthetic triterpenoids: p ...... lammatory and oxidative stress
@nl
P2093
P2860
P921
P3181
P356
P1476
New synthetic triterpenoids: p ...... lammatory and oxidative stress
@en
P2093
Gordon W Gribble
Justin M Lopchuk
Karen T Liby
Liangfeng Fu
Mark M Yore
Michael B Sporn
P2860
P304
P3181
P356
10.1021/NP100826Q
P407
P577
2011-03-25T00:00:00Z